Cigna Corp
NYSE:CI
Cigna Corp
NYSE:CI
Price:
339.26 USD
-1.17%
Market Closed
Updated:
May 16, 2024
Cigna Corp
Operating Income
|
Cigna Corp
Operating Income Peer Comparison
Comparables:
DVA
CHE
DGX
CVS
LH
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cigna Corp
NYSE:CI
|
Operating Income
$9.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
DaVita Inc
NYSE:DVA
|
Operating Income
$1.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
|
Chemed Corp
NYSE:CHE
|
Operating Income
$373.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Income
$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
CVS Health Corp
NYSE:CVS
|
Operating Income
$13.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Income
$1.1B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
See Also
What is Cigna Corp's Operating Income?
Operating Income
9.3B
USD
9.3B
USD
Based on the financial report for Mar 31, 2024, Cigna Corp's Operating Income amounts to 9.3B USD.
What is Cigna Corp's Operating Income growth rate?
Operating Income CAGR 10Y
12%
12%
Over the last year, the Operating Income growth was 13%. The average annual Operating Income growth rates for Cigna Corp have been 3% over the past three years , 13% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
